CD164 is a host factor for lymphocytic choriomeningitis virus entry.


Journal

Proceedings of the National Academy of Sciences of the United States of America
ISSN: 1091-6490
Titre abrégé: Proc Natl Acad Sci U S A
Pays: United States
ID NLM: 7505876

Informations de publication

Date de publication:
08 03 2022
Historique:
entrez: 2 3 2022
pubmed: 3 3 2022
medline: 22 3 2022
Statut: ppublish

Résumé

Lymphocytic choriomeningitis virus (LCMV) is a rodent-borne zoonotic arenavirus that causes congenital abnormalities and can be fatal for transplant recipients. Using a genome-wide loss-of-function screen, we identify host factors required for LCMV entry into cells. We identify the lysosomal mucin CD164, glycosylation factors, the heparan sulfate biosynthesis machinery, and the known receptor alpha-dystroglycan (α-DG). Biochemical analysis revealed that the LCMV glycoprotein binds CD164 at acidic pH and requires a sialylated glycan at residue N104. We demonstrate that LCMV entry proceeds by the virus switching binding from heparan sulfate or α-DG at the plasma membrane to CD164 prior to membrane fusion, thus identifying additional potential targets for therapeutic intervention.

Identifiants

pubmed: 35235462
doi: 10.1073/pnas.2119676119
pmc: PMC8915965
doi:

Substances chimiques

CD164 protein, human 0
Endolyn 0
Virulence Factors 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e2119676119

Subventions

Organisme : NIAID NIH HHS
ID : F31 AI154700
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI007245
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI125179
Pays : United States
Organisme : NIAID NIH HHS
ID : U19 AI109740
Pays : United States

Références

J Virol. 2015 Nov;89(21):10924-33
pubmed: 26292327
Science. 2005 Jun 10;308(5728):1643-5
pubmed: 15831716
Pathogens. 2021 May 28;10(6):
pubmed: 34071689
Nat Microbiol. 2018 Oct;3(10):1153-1160
pubmed: 30150732
Blood. 1998 Aug 1;92(3):849-66
pubmed: 9680353
Am J Obstet Gynecol. 2006 Jun;194(6):1532-6
pubmed: 16731068
Nature. 2011 Aug 24;477(7364):340-3
pubmed: 21866103
Proc Natl Acad Sci U S A. 2011 May 17;108(20):8426-31
pubmed: 21536871
J Gen Virol. 2012 Oct;93(Pt 10):2247-2251
pubmed: 22815269
Structure. 2005 May;13(5):803-15
pubmed: 15893670
N Engl J Med. 2006 May 25;354(21):2235-49
pubmed: 16723615
Nat Biotechnol. 2016 Feb;34(2):184-191
pubmed: 26780180
Nature. 2011 Aug 24;477(7364):344-8
pubmed: 21866101
Virology. 2004 Aug 1;325(2):432-45
pubmed: 15246281
Proc Natl Acad Sci U S A. 1995 Aug 29;92(18):8388-92
pubmed: 7667300
Virology. 1994 Jan;198(1):1-9
pubmed: 8259643
Nature. 2007 Mar 1;446(7131):92-6
pubmed: 17287727
Science. 1998 Dec 11;282(5396):2079-81
pubmed: 9851928
J Exp Med. 1936 Jul 31;64(2):183-200
pubmed: 19870529
Viruses. 2013 Jan 17;5(1):241-78
pubmed: 23344562
Nat Struct Mol Biol. 2016 Jun;23(6):513-521
pubmed: 27111888
J Biol Chem. 2003 Oct 24;278(43):41914-20
pubmed: 12917426
J Virol. 1999 Jan;73(1):251-9
pubmed: 9847328
Nature. 1993 Apr 22;362(6422):758-61
pubmed: 8469287
Front Microbiol. 2018 Aug 03;9:1751
pubmed: 30123198
J Virol. 2009 May;83(9):4121-6
pubmed: 19224989
EMBO J. 2001 Nov 15;20(22):6256-64
pubmed: 11707397
PLoS Pathog. 2009 May;5(5):e1000455
pubmed: 19478873
J Virol. 2016 Jul 11;90(15):6799-807
pubmed: 27194767
Proc Natl Acad Sci U S A. 2011 Sep 20;108(38):16026-31
pubmed: 21896745
Glycobiology. 1997 Jun;7(4):469-79
pubmed: 9184827
J Immunol. 2000 Jul 15;165(2):840-51
pubmed: 10878358
J AAPOS. 2018 Feb;22(1):79-81.e1
pubmed: 29274373
J Virol. 2010 Jan;84(1):163-75
pubmed: 19846533
Nature. 1974 Oct 11;251(5475):547-8
pubmed: 4547543
J Biochem. 1998 Jul;124(1):171-8
pubmed: 9644260
Virology. 1994 Feb;198(2):455-65
pubmed: 8291229
PLoS Pathog. 2021 Oct 14;17(10):e1009996
pubmed: 34648606
Am J Obstet Gynecol. 2002 Dec;187(6):1715-6
pubmed: 12501090
Virology. 2013 Feb 5;436(1):127-33
pubmed: 23218200
Science. 2013 Apr 26;340(6131):479-83
pubmed: 23519211
Science. 2014 Jun 27;344(6191):1506-10
pubmed: 24970085
J Virol. 1989 Jan;63(1):52-8
pubmed: 2535752
J Virol. 2008 Nov;82(21):10932-9
pubmed: 18768973
Curr Protoc Microbiol. 2008 Feb;Chapter 15:Unit 15A.1
pubmed: 18770534
Science. 2017 Jun 2;356(6341):923-928
pubmed: 28572385
Virology. 2003 Sep 15;314(1):168-78
pubmed: 14517070
J Virol. 2016 Jan 20;90(7):3640-9
pubmed: 26792739
J Virol. 2008 Feb;82(3):1505-17
pubmed: 18045945
J Virol. 2011 Aug;85(16):8105-15
pubmed: 21680501
Emerg Infect Dis. 2010 Jul;16(7):1093-100
pubmed: 20587180
Am J Trop Med Hyg. 1997 Jul;57(1):37-41
pubmed: 9242315
J Virol. 2007 Jun;81(11):5685-95
pubmed: 17360738
J Biol Chem. 2000 Feb 11;275(6):3781-6
pubmed: 10660527
Nat Med. 1997 Aug;3(8):866-71
pubmed: 9256277
Virology. 2003 Jan 5;305(1):115-23
pubmed: 12504546
Genet Vaccines Ther. 2011 Apr 08;9:8
pubmed: 21477292
J Cell Biol. 1998 Apr 6;141(1):115-33
pubmed: 9531552
J Exp Med. 1984 Aug 1;160(2):521-40
pubmed: 6332167
N Engl J Med. 2008 Mar 6;358(10):991-8
pubmed: 18256387
Structure. 1998 Jun 15;6(6):793-801
pubmed: 9655832
Emerg Infect Dis. 2017 Sep;23(9):1548-1550
pubmed: 28820372
J Virol. 2003 Mar;77(5):2866-72
pubmed: 12584310
Cell Host Microbe. 2017 Nov 8;22(5):688-696.e5
pubmed: 29120745
PLoS Pathog. 2009 Apr;5(4):e1000358
pubmed: 19343214
Proc Natl Acad Sci U S A. 2011 Oct 18;108(42):17426-31
pubmed: 21987822
Viruses. 2019 Jun 14;11(6):
pubmed: 31207945
Blood. 1998 Oct 15;92(8):2613-28
pubmed: 9763543
J Cell Biol. 2001 Oct 15;155(2):301-10
pubmed: 11604425
Ann Neurol. 2007 Oct;62(4):356-74
pubmed: 17696127
Arch Virol. 1996;141(7):1307-17
pubmed: 8774689
Traffic. 2004 Dec;5(12):946-62
pubmed: 15522097
Cell. 2004 Jun 25;117(7):953-64
pubmed: 15210115
Biochem J. 2000 Jan 15;345 Pt 2:287-96
pubmed: 10620506
Emerg Infect Dis. 2014 Feb;20(2):240-7
pubmed: 24447605
PLoS Pathog. 2007 Nov;3(11):e149
pubmed: 18052527

Auteurs

Mark J G Bakkers (MJG)

Department of Microbiology, Harvard Medical School, Boston, MA 02115.

Alex Moon-Walker (A)

Department of Microbiology, Harvard Medical School, Boston, MA 02115.
Program in Virology, Harvard Medical School, Boston, MA 02115.
Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037.
Department of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO 63110.

Rasmus Herlo (R)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115.

Vesna Brusic (V)

Department of Microbiology, Harvard Medical School, Boston, MA 02115.

Sarah Hulsey Stubbs (SH)

Department of Microbiology, Harvard Medical School, Boston, MA 02115.

Kathryn M Hastie (KM)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037.

Erica Ollmann Saphire (EO)

Center for Infectious Disease and Vaccine Research, La Jolla Institute for Immunology, La Jolla, CA 92037.

Tomas L Kirchhausen (TL)

Department of Cell Biology, Harvard Medical School, Boston, MA 02115.
Department of Pediatrics, Harvard Medical School, Boston, MA 02115.

Sean P J Whelan (SPJ)

Department of Microbiology, Harvard Medical School, Boston, MA 02115.
Department of Molecular Microbiology, Washington University in St. Louis, St. Louis, MO 63110.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH